Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway

Figure 5

Scheme of miR-9 mediates the inhibition of DMY on M1 macrophage polarization in atherosclerosis.